Long-term treatment of osteopetrosis with recombinant human interferon gamma.
about
Osteoimmunology: interactions of the bone and immune systemExposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiationTherapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug DiscoveryOsteoimmune Interactions in Inflammatory Bowel Disease: Central Role of Bone Marrow Th17 TNFα Cells in OsteoclastogenesisOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsEstrogen regulation of immune cell bone interactionsA new superoxide-generating oxidase in murine osteoclastsHuman malignant osteopetrosis: Pathophysiology, management and the role of bone marrow transplantationInterferon alpha treatment of patients with impaired interferon gamma signaling.Autosomal recessive osteopetrosis: diagnosis, management, and outcome.T cells: critical bone regulators in health and disease.The immune system and bone.Successful staged hip replacement in septic hip osteoarthritis in osteopetrosis: a case report.PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.Radiologic resolution of malignant infantile osteopetrosis skeletal changes following hematopoietic stem cell transplantation.Estrogen deficiency and bone loss: an inflammatory tale.Nothing but skin and bone.Diseases affecting bone quality: beyond osteoporosis.IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors.Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity.Generalized osteosclerosis in a cat.Osteopetrosis in two siblings: two case reportsIncreased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatographyThe role of T lymphocytes in bone metabolism.Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis.Functions of RANKL/RANK/OPG in bone modeling and remodeling.Osteoclasts-Key Players in Skeletal Health and Disease.Towards a better understanding and new therapeutics of osteopetrosis.Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.A newborn twin with unusual chest radiographAssociation between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patientsOsteoimmunology: cytokines and the skeletal system.The Effect of Long-Term Exercise on the Production of Osteoclastogenic and Antiosteoclastogenic Cytokines by Peripheral Blood Mononuclear Cells and on Serum Markers of Bone Metabolism.Influence of signal transducer and activator of transcription-1 signaling on thyroid morphology and functionThe Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro.Estrogen prevents bone loss through transforming growth factor beta signaling in T cells.Role of T cells in ovariectomy induced bone loss--revisited.Cells of the immune system orchestrate changes in bone cell function.
P2860
Q24655113-EDE4D382-3F45-4440-9DF4-2621781114A9Q24796088-05DD4E27-479E-40F6-BF0F-74FB548DC7FEQ26744730-FC0DAC73-AE5B-4EB2-B9E4-4B578FE8884DQ26770666-A5209C81-8B30-4695-8728-6C246CA83D79Q26828486-D005BB5E-7D6D-4770-B3B5-9E41D88F950FQ28251201-A01DFF16-7D40-4C44-BFF0-A4F21DB6F809Q28587361-414A7096-B43F-476E-8A88-F8F1D6E528A4Q29399804-42AB20C8-524A-49F0-B58C-0480349299B4Q34059742-8A7F8D2E-0E17-4E36-88A0-945C993343EBQ34065111-C3BA4FBF-BA6A-41DE-AF4A-0B6F9B06FA4FQ34079698-CF0EC733-FBA0-41E1-87F7-71A5BF455051Q34143343-CB7B5B4B-C098-4754-998B-0679E2D08015Q34218965-34C37BC1-ABE3-4629-A516-BFAAA879DC1FQ34294045-B598F75A-4966-4E5D-838B-2F9DF1B2936CQ34469225-B66D63F5-53C9-450E-91EC-411F4B960651Q34576622-795BA6A8-8051-4DE8-BB68-309D6B5456F8Q34576635-6C5DC257-6FE9-459B-9B82-DB46DEA0F80AQ35078847-F7523B08-7FA3-463A-98FA-CEEB7CE382FFQ35219971-A73EF4CF-CD2C-4832-BBD4-0EDAA35B4997Q35617591-04362FE1-DA23-42DC-837D-4CC40E81B99FQ35855534-7C856777-AD68-4E4A-BCEB-49478135E66DQ35890162-242811E9-AD92-4CAF-A8B8-AC9D4DA7B50BQ35908627-23850DC8-6850-44D5-BD8E-039EA7C7165BQ36055511-EF023CDB-418A-41C2-AFF1-EDBF53E98226Q36324949-051D4EC4-2F0F-41D2-A783-C67CFCE2076BQ36600260-5E96F932-5B5B-4E62-B3A4-020DF1E78A51Q36700779-44C74AEF-29A9-44AA-BC7D-FD423F096B11Q37036135-05F57D69-F45F-444B-8ECB-9D327CB88F64Q37074250-84D3761D-C1D7-4AA6-9783-006C331A473AQ37094204-3DBF9A0A-6A24-4C80-A0A8-596D78D5DFFCQ37139614-70C617F3-84F7-4AAE-B9A2-99FB6A0790A6Q37202922-9EDF8DBB-6010-45E4-BF16-1F9E47E887E8Q37235713-11761ACC-9A7A-4880-ADD7-6191D955F04CQ37236070-D8FA0611-19FE-4014-90B5-E9BE254EB8A1Q37244622-FBC9ED84-BB01-4CD6-9AC1-AFB8116AF946Q37287589-2F9D8377-E2D7-4117-A777-39A125BDE51CQ37310557-97B1EDB5-41B9-4477-BB8D-AC279C18365AQ37692440-69A9A0FA-EEA8-48CD-98FC-52C0C8E84C0AQ37978237-F630103B-B964-427C-BA40-05C993909881Q38126407-A8020E16-3B23-401F-AA89-9A77EC248C1E
P2860
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@ast
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@en
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@nl
type
label
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@ast
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@en
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@nl
prefLabel
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@ast
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@en
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@nl
P2093
P1476
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
@en
P2093
H C Hatcher
N M Wright
P P Griffin
R M Rodriguiz
P304
P356
10.1056/NEJM199506153322402
P407
P577
1995-06-01T00:00:00Z